Cardiac Implantable Electronic Device-Detected Atrial Fibrillation - “To anticoagulate or not to anticoagulate, that is the question”: The Noble or Ignoble Choice?

Atrial fibrillation (AF) detected during interrogation of a cardiovascular implantable electronic device (CIED) is a common event1 with available studies suggesting that it is associated with an increased risk of stroke.2,3 While current guidelines recommend oral anticoagulant (OAC) therapy for AF patients with an elevated CHA2DS2-VASc score,4 controversy exists about whether the various components of CIED-detected AF (e.g. duration, burden, CHA2DS2-VASc score, etc.) predict stroke and, if effective as predictors, which characteristics best define that risk.

Source: Heart Rhythm - November 9, 2020 Category: Cardiology Authors: Thomas F. Deering, Faiez Zannad Source Type: research